Zafirlukast
NDC 68151-1977
Product Information
Zafirlukast is a ANDA-approved product labeled by Carilion Materials Management. Zafirlukast is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. It is supplied as a white product. This product entry covers the primary NDC 68151-1977 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
R;626
Code Structure Chart
Product Details
What is NDC 68151-1977?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ZAFIRLUKAST (UNII: XZ629S5L50)
- ZAFIRLUKAST (UNII: XZ629S5L50) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- HYDROXYPROPYL CELLULOSE (TYPE H) (UNII: RFW2ET671P)
- HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
- SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 199655 - zafirlukast 20 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.